630
Participants
Start Date
August 31, 2012
Primary Completion Date
July 31, 2016
Study Completion Date
July 31, 2016
cabazitaxel
Cabazitaxel (25mg/m² IV) is administered on day 1 of each 21-day cycle until disease progression, unacceptable toxicity, or completion of 10 cycles
prednisone
Prednisone (10 mg PO) is administered daily until disease progression, unacceptable toxicity, or completion of 10 cycles
custirsen sodium
Custirsen is administered as 3 loading doses (640 mg IV each) within 9 days, followed by weekly custirsen (640 mg IV) during each 21-day cycle until disease progression, unacceptable toxicity, or completion of 10 cycles
Prostate Oncology Specialists, Marina del Rey
University of California Davis Medical Center, Sacramento
Sharp Health Care, San Diego
California Pacific Medical Center Research Institute, San Francisco
Rocky Mountain Cancer Center, Boulder
Hartford Hospital, Hartford
Smilow Cancer Hospital at Yale New Haven Hospital, New Haven
The Center for Hematology-Oncology, Boca Raton
Florida Cancer Specialists, Fort Myers
Florida Cancer Specialists, Inverness
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Georgia Cancer Specialists, P.C., Marietta
Cancer Center of Kansas, Wichita
Boston University Medical Center, Boston
University of Michigan Health System, Ann Arbor
Karmanos Cancer Institute, Detroit
Washington University School of Medicine, St Louis
Urology Cancer Center and GU Research Network, Omaha
Monter Cancer Center, Lake Success
SUNY Upstate Medical University, Syracuse
Albert Einstein Medical Center, The Bronx
Blumenthal Cancer Center, Charlotte
Cancer Centers of North Carolina, Raleigh
Oncology Hematology Care, Inc., Blue Ash
The Mark H. Zangmeister Center, Columbus
Oregon Health and Science University, Portland
South Carolina Oncology Associates, Columbia
Cancer Centers of the Carolinas, Greenville
Chattanooga Oncology and Hematology Associates, Chattanooga
The West Clinic, Memphis
Tennessee Oncology, PLLC, Nashville
Texas Oncology, PA, Dallas
Utah Cancer Specialists, Salt Lake City
Virginia Oncology Associates, Norfolk
Virginia Cancer Institute, Richmond
The Canberra Hospital, Garran
Royal Prince Alfred Hospital, Camperdown
St George Public Hospital, Kogarah
Royal North Shore Hospital, Saint Leonards
Westmead Hospital, Westmead
Haematology and Oncology Clinics of Australia, Brisbane
The Queen Elizabeth Hospital, Woodville South
Royal Hobart Hospital, Hobart
Box Hill Hospital, Box Hill
Austin Health, Heidelberg
Epworth Healthcare, Richmond
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency, Vancouver
Juravinski Cancer Centre, Hamilton
London Health Sciences Center, London
R. S. McLaughlin Durham Regional Cancer Center at Lakeridge Health Oshawa, Oshawa
The Ottawa Hospital Regional Cancer Centre, Ottawa
Sunnybrook Health Sciences Centre, Toronto
CHUM-Hospital Notre-Dame, Montreal
Krajská nemocnice Liberec a.s., Liberec
Krajská nemo. T.Bati, a. s., Zlín
Fakultni nemo Hradec Králové, Hradec Králové
University Hospital Olomouc, Olomouc
Centre Léon Bérard, Lyon Cédex 08
Centre François Baclesse, Caen
Institut Jean-Godinot, Reims
Institut Paoli Calmettes, Marseille
Institut de Cancérologie de l'Ouest - René Gauducheau, Saint-Herblain
Centre Hospitalier Universitaire de Poitiers Hôpital de la Milétrie, Poitiers
Centre Antoine Lacassagne, Nice
Hôpital Saint Louis, Paris
Institut Curie, Paris
Institut Gustave Roussy, Villejuif
Pándy Kálmán Megyei Kórház, Gyula
Borsod Abaúj Zemplén Megyei Kórház és Egyetemi Oktató Kórház, Miskolc
Országos Onkológiai Intézet, Budapest
Semmelweis Egyetem Általános Orvostudományi Kar, Budapest
Szegedi Tudományegyetem, Onkoterápiás Klinika, Szeged
Ivanovo Reg Oncology Centre, Ivanovo
Cancer Research Center na NN Blokhin, Moscow
Hertzen Rsrch Inst of Oncology, Moscow
Sverdlovsk Reg Clin Hosp#1, Yekaterinburg
Volgograd Regional Oncological Dispensary, Volzhsky
S Inst Hlth Altay Reg Onc Disp, Barnaul
Russian Research Center of Radiology, Moscow
Urology Research Institute, Moscow
State Healthcare Inst Omsk Reg, Omsk
Petrov Research Oncology Institute, Saint Petersburg
Saint Petersburg City Oncological Dispensary, Saint Petersburg
Stavropol Reg Oncology Ctr, Stavropol
Cancer Research UK, Birmingham
Addenbrookes Hospital Cambridge, Cambridge
U of Surrey Post Grad Med, Guildford
Christie Hospital NHS Foundation Trust, Manchester
Clatterbridge Centre for Oncology NHS Foundation Trust, Metropolitan Borough of Wirral
Nottingham City Hospital NHS Trust, Nottingham
The Royal Marsden Hospital, Surrey
Musgrove Park Hospital, Taunton
Beatson Cancer Centre, Glasgow, Glasgow
Lead Sponsor
Achieve Life Sciences
INDUSTRY